Articles from Duo Health

Duo Health, a new type of value-based medical group for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced the hire of Kristen Warden as President and Chief Operations Officer. Warden brings extensive experience in operating and growing value-based care organizations.

Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers health benefits through individual, Medicaid, Medicare and dual-eligible programs and a Centene Corporation company (NYSECNC). This partnership builds on Arizona Complete Health’s existing value-based care nephrology network arrangements and is designed to enhance patient engagement and improve outcomes for Medicare members with CKD and ESKD.

Duo Health, a new type of medical group purpose-built to care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in value-based collaborations with local providers, announced the appointment of Raul Smith as Chief Financial Officer. Smith brings nearly two decades of financial leadership and growth-stage executive experience to the role, where he will lead Duo Health’s strategic financial operations.

Duo Health (Duo), a new type of medical group for patients with chronic kidney disease (CKD) and end stage kidney disease (ESKD) announces partnership with Gold Kidney Health Plan (Gold Kidney) to deliver an enhanced model of care for patients in Arizona.

In response to continued growth and expansion, Duo Health, a new type of value-based medical group purpose-built to comprehensively care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in collaborative relationships with local providers announced the appointment of Jay Shah, MD, MBA as Chief Growth Officer. Dr. Shah joins Duo to lead the organization’s ongoing growth and expansion as an outcomes-focused physician with more than two decades of business development and consulting experience designing, launching, and growing innovative value-based care solutions to clients transitioning from a volume to value-based payment environment.

Duo Health announced today a first-of-its-kind partnership in Arizona with Desert Kidney Associates (DKA), a nephrology practice with longstanding community ties. Duo Health is a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in collaborative relationships with nephrology and multi-specialty practices. Duo Health brings advanced technology, a proven clinical model and deep domain expertise in patient engagement to give unmatched participation by nephrologists in the value the partnership creates together.

Duo Health, a new type of medical group for patients with chronic kidney disease (CKD) and end stage kidney disease (ESKD) announces the appointment of Bryan Adams, PhD, as Chief Technical Officer. Adams is a seasoned technology leader in developing solutions for medical devices, remote patient monitoring and passive analytics that drive improved care models for complex and aging populations. His addition bolsters Duo’s commitment to their Health Mobilization™ Platform, which brings an unprecedented level of instrumentation across the patient experience aimed at driving continuously better outcomes.

Duo Health, a new type of medical group for patients with chronic kidney disease (CKD) and end stage kidney disease (ESKD) announces the appointment of Richard Barager, MD, FACP as Chief Medical Officer and Anthony Perry, MD as Chief Clinical Officer. Barager is a distinguished nephrologist with more than 35 years of practice and deep experience as a physician, medical practice owner, and NACD-certified Board Director. Perry is a physician-leader with foundation in geriatric medical services and demonstrated success in experiences ranging from hospital operations leadership to integrated physician practice leadership. The experienced and complementary clinical leadership exemplifies Duo’s mission to pioneer true value-based care in the CKD space.

Duo Health, a new type of globally capitated medical group, is launching in multiple markets in 2022 to address challenges of patients, physicians and plans in the face of chronic kidney disease (CKD) and end stage kidney disease (ESKD). The prevalence of CKD and ESKD represents a public health crisis for the 1 in 7 American adults affected, and its status quo treatment contributes significantly to health inequity in the country.